Publicação
Impacto clínico em curto e longo prazo da Válvula Aórtica Percutânea (VAP) em Portugal de acordo com diferentes acessos – Dados do Registo Nacional de Cardiologia de Intervenção de VAP
| dc.contributor.author | Guerreiro, Cláudio | |
| dc.contributor.author | Ferreira, Pedro Carrilho | |
| dc.contributor.author | Teles, Rui Campante | |
| dc.contributor.author | Braga, Pedro | |
| dc.contributor.author | Canas da Silva, Pedro | |
| dc.contributor.author | Patrício, Lino | |
| dc.contributor.author | Silva, João Carlos | |
| dc.contributor.author | Baptista, José | |
| dc.contributor.author | de Sousa Almeida, Manuel | |
| dc.contributor.author | Gama Ribeiro, Vasco | |
| dc.contributor.author | Silva, Bruno | |
| dc.contributor.author | Brito, João | |
| dc.contributor.author | Infante Oliveira, Eduardo | |
| dc.contributor.author | Cacela, Duarte | |
| dc.contributor.author | Madeira, Sérgio | |
| dc.contributor.author | Silveira, João | |
| dc.contributor.institution | NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) | |
| dc.contributor.pbl | Sociedade Portuguesa de Cardiologia | Elsevier | |
| dc.date.accessioned | 2023-01-12T22:15:45Z | |
| dc.date.available | 2023-01-12T22:15:45Z | |
| dc.date.issued | 2020-12 | |
| dc.description.abstract | Introduction: The Portuguese National Registry of Transcatheter Aortic Valve Implantation records prospectively the characteristics and outcomes of transcatheter aortic valve implantation (TAVI) procedures in Portugal. Objectives: To assess the 30-day and one-year outcomes of TAVI procedures in Portugal. Methods: We compared TAVI results according to the principal access used (transfemoral (TF) vs. non-transfemoral (non-TF)). Cumulative survival curves according to access route, other procedural and clinical variables were obtained. The Valve Academic Research Consortium-2 (VARC-2) composite endpoint of early (30-days) safety was assessed. VARC-2 predictors of 30-days and 1-year all-cause mortality were identified. Results: Between January 2007 and December 2018, 2346 consecutive patients underwent TAVI (2242 native, 104 valve-in-valve; mean age 81±7 years, 53.2% female, EuroSCORE-II - EuroS-II, 4.3%). Device success was 90.1% and numerically lower for non-TF (87.0%). Thirty-day all-cause mortality was 4.8%, with the TF route rendering a lower mortality rate (4.3% vs. 10.1%, p=0.001) and higher safety endpoint (86.4% vs. 72.6%, p<0.001). The one-year all-cause mortality rate was 11.4%, and was significantly lower for TF patients (10.5% vs. 19.4%, p<0.002). After multivariate analysis, peripheral artery disease, previous percutaneous coronary intervention, left ventricular dysfunction and NYHA class III-IV were independent predictors of 30-day all-cause mortality. At one-year follow-up, NYHA class III-IV, non-TF route and occurrence of life-threatening bleeding predicted mortality. Kaplan-Meier survival analysis of the first year of follow-up shows decreased survival for patients with an EuroS-II>5% (p<0.001) and who underwent non-TF TAVI (p<0.001). Conclusion: Data from our national real-world registry showed that TAVI was safe and effective. The use of a non-transfemoral approach demonstrated safety in the short term. Long-term prognosis was, however, adversely associated with this route, with comorbidities and the baseline clinical status. | en |
| dc.description.version | publishersversion | |
| dc.description.version | published | |
| dc.format.extent | 13 | |
| dc.format.extent | 1519227 | |
| dc.identifier.doi | 10.1016/j.repc.2020.02.014 | |
| dc.identifier.issn | 0870-2551 | |
| dc.identifier.other | PURE: 27716010 | |
| dc.identifier.other | PURE UUID: f2d83107-caaf-455d-b12d-0e0809a90829 | |
| dc.identifier.other | Scopus: 85097457188 | |
| dc.identifier.other | PubMed: 33261991 | |
| dc.identifier.other | WOS: 000605402400007 | |
| dc.identifier.uri | http://hdl.handle.net/10362/147428 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/85097457188 | |
| dc.language.iso | por | |
| dc.peerreviewed | yes | |
| dc.subject | Heart failure | |
| dc.subject | Severe aortic valvular disease | |
| dc.subject | TAVI | |
| dc.subject | Cardiology and Cardiovascular Medicine | |
| dc.title | Impacto clínico em curto e longo prazo da Válvula Aórtica Percutânea (VAP) em Portugal de acordo com diferentes acessos – Dados do Registo Nacional de Cardiologia de Intervenção de VAP | pt |
| dc.title.alternative | Short and long-term clinical impact of transcatheter aortic valve implantation in Portugal according to different access routesData from the Portuguese National Registry of TAVI | en |
| dc.type | journal article | |
| degois.publication.firstPage | 705 | |
| degois.publication.issue | 12 | |
| degois.publication.lastPage | 717 | |
| degois.publication.title | Revista Portuguesa de Cardiologia | |
| degois.publication.volume | 39 | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess |
Ficheiros
Principais
1 - 1 de 1
A carregar...
- Nome:
- 1_s2.0_S0870255120304364_main.pdf
- Tamanho:
- 1.45 MB
- Formato:
- Adobe Portable Document Format
